{
  "id": "644298cc57b1c7a315000062",
  "type": "factoid",
  "question": "What is the cause of Facioscapulohumeral Muscular Dystrophy type 2 (FSHD2)?",
  "ideal_answer": "FSHD2 is caused by mutations in the protein regulating the methylation status of chromatin - SMCHD1.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29980640",
    "http://www.ncbi.nlm.nih.gov/pubmed/34711481",
    "http://www.ncbi.nlm.nih.gov/pubmed/30871534",
    "http://www.ncbi.nlm.nih.gov/pubmed/24128691",
    "http://www.ncbi.nlm.nih.gov/pubmed/30923442",
    "http://www.ncbi.nlm.nih.gov/pubmed/29402602",
    "http://www.ncbi.nlm.nih.gov/pubmed/30327220",
    "http://www.ncbi.nlm.nih.gov/pubmed/28915324"
  ],
  "snippets": [
    {
      "text": "Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30871534",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "FSHD2 is caused by the mutations in the protein regulating the methylation status of chromatin - SMCHD1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30871534",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Given the previous report of SMCHD1 mutations in FSHD2 and the clinical presentations consistent with the FSHD phenotype, we conclude that the SMCHD1 mutation is the likely cause of the disease in this family.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24128691",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24128691",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recently, mutations in SMCHD1 combined with a permissive 4q35 allele were reported to cause FSHD2.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24128691",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Facioscapulohumeral muscular dystrophy type 2 (FSHD2) accounts for approximately 5% of all cases of FSHD and describes patients without a D4Z4 repeat contraction on chromosome 4.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34711481",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Type 1 facioscapulohumeral muscular dystrophy (FSHD) is caused by contraction of D4Z4 repeats on 4q35, whereas type 2 FSHD is associated with mutations of the SMCHD1 or DNMT3B gene in the presence of a disease-permissive 4qA haplotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30923442",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Facioscapulohumeral muscular dystrophy (FSHD) 2 is caused by a combination of heterozygous structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1) mutation plus DNA hypomethylation on D4Z4.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30327220",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The less common form of the disease, FSHD2, results from haploinsufficiency of the SMCHD1 gene in individuals carrying a permissive 4qA allele, also leading to the derepression of DUX4, further supporting a central role for DUX4.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28915324",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "iduals and 1-10 repeats in patients), and FSHD2 is caused by mutations in SMCHD1 or DNMT3B. Here, we present clinical features and results of genetic ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29402602",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To determine whether congenital arhinia/Bosma arhinia microphthalmia syndrome (BAMS) and facioscapulohumeral muscular dystrophy type 2 (FSHD2), 2 seemingly unrelated disorders both caused by heterozygous pathogenic missense variants in the SMCHD1 gene, might represent different ends of a broad single phenotypic spectrum associated with SMCHD1 dysfunction",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29980640",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "autosomal dominant disease, ectopic expression of the transcription factor DUX4 in skeletal muscle, mutations in the protein regulating the methylation status of chromatin - SMCHD1"
}